| Literature DB >> 35813427 |
Abstract
Chloasma is a prevalent clinical hyperpigmentation skin disorder that causes symmetrical brown to tan patches on the cheeks, as well as the neck and forearms on rare occasions. The pathophysiology of this condition is complicated, and there is now no cure. Under the light microscope, the full-thickness melanin of the epidermis in the skin lesions was increased, and the dermal chromophages increased. At present, the treatment of melasma mainly includes topical drugs, chemical peels, systemic drugs, laser therapy, and traditional Chinese medicine. With the development of medical technology, intense pulsed light and Q-switched laser have been widely used in the treatment of melasma, which can emit laser beams to penetrate the dermis uniformly to treat deep pigmented lesions in the dermis. After a stable treatment outcome for melasma is achieved, it is important to minimize side effects such as postinflammatory hyperpigmentation and skin irritation. Therefore, this paper uses a reflection confocal microscope to establish an evaluation index system and then uses a neural network to evaluate the treatment effect. The work of this paper is as follows: (1) this paper introduces various methods of treating melasma at home and abroad and focuses on the application of intense pulsed light therapy and low-energy Q-switched Nd: YAG laser in the treatment of melasma. (2) In this paper, the case data samples are trained with the designed BP network to obtain a reliable evaluation network model. (3) The results and mistakes of the evaluation are produced by training the genetic algorithm optimized backpropagation (GA-BP) network structure model to evaluate the treatment effect of chloasma. Finally, it has been demonstrated that the GA-BP network has great accuracy and stability.Entities:
Mesh:
Year: 2022 PMID: 35813427 PMCID: PMC9270135 DOI: 10.1155/2022/4413130
Source DB: PubMed Journal: Comput Math Methods Med ISSN: 1748-670X Impact factor: 2.809
Figure 1Network error definition and weight adjustment ideas.
Figure 2GA-BP neural network model structure diagram.
Range of MASI reduction rate and treatment effect.
| Treatment effect | MASI decline rate range |
|---|---|
| Basically healed | MASI decline rate ≥ 90% |
| Effective | MASI decline rate 50%~89% |
| Get better | MASI decline rate 10%~49% |
| Invalid | MASI decline rate < 10% |
Scoring criteria of each parameter of RCM.
| Parameters | 1 | 2 | 3 | 4 |
|---|---|---|---|---|
| Epidermal pigmentation | <25.0% | 26.0%-50.0% | 51.0%-75.0% | 76.0%-100% |
| Dendritic cells | None | ≤5 | ≤15 | >15 |
| Melanophages | None | ≤5 | ≤10 | >10 |
| Solar elastosis | Normal | Mild | Moderate | Serious |
| Vascularity | Normal | Mild | Moderate | Serious |
Figure 3When the training curve is 138 steps, the convergence reaches the set accuracy.
Validation results of the BP network model.
| Sample | Expected output | BP model output | Error |
|---|---|---|---|
| 1 | 0.151 | 0.125 | 0.024 |
| 2 | 0.243 | 0.273 | 0.033 |
| 3 | 0.060 | 0.092 | 0.032 |
| 4 | 0.192 | 0.214 | 0.024 |
| 5 | 0.533 | 0.483 | 0.046 |
| 6 | 0.582 | 0.561 | 0.018 |
| 7 | 0.422 | 0.442 | 0.022 |
| 8 | 0.3704 | 0.451 | 0.081 |
| 9 | 0.450 | 0.472 | 0.022 |
| 10 | 1.161 | 0.127 | 1.032 |
Figure 4Variation of fitness curve when the genetic algorithm optimizes neural network.
Figure 5Comparison between the output of different models and the expected output.